TDR reviews DEA's push against further rescheduling delays

The Dales Report explains that DEA does not oppose admitting the GAO scheduling-process report but argues that it does not justify new briefing, testimony or discovery. Oklahoma medical operators should watch whether the administrative judge merely adds the report or reopens the record, because only the latter would create a larger new delay risk.